Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionJacobs & Co/ca
Latest Disclosed Ownership3,580 shares
Latest Disclosed Value $ 217
Jacobs & Co/ca ownership in BRM / Bristol-Myers Squibb Company

On April 7, 2026 - Jacobs & Co/ca filed a 13F-HR form disclosing ownership of 3,580 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $187,664 USD as of March 31, 2026. The entity filed a previous 13F-HR on July 2, 2025 disclosing 0 shares of Bristol-Myers Squibb Company. The current value of the position is $169,817 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F Bristol-Myers Squibb COM 110122108 3,580 3,580 0 0.0214
2025-07-02 2025-06-30 13F Bristol-MyersSquibbCo COM 110122108 0 -100.00 0
2025-04-03 2025-03-31 13F Bristol-MyersSquibbCo COM 110122108 4,205 0 0.00 0 0.0273
2025-01-10 2024-12-31 13F Bristol-MyersSquibbCo COM 110122108 4,205 -264 -5.91 0 0.0241
2024-10-01 2024-09-30 13F Bristol-Myers Squibb COM 110122108 4,469 -22,820 -83.62 0 -100.00 0.0231
2024-07-12 2024-06-30 13F Bristol-Myers Squibb COM 110122108 27,289 -101,039 -78.73 1 -83.33 0.1187
2024-04-12 2024-03-31 13F Bristol-MyersSquibbCo COM 110122108 128,328 1,014 0.80 7 0.00 0.7367
2024-01-18 2023-12-31 13F Bristol-MyersSquibbCo COM 110122108 127,314 907 0.72 7 -14.29 0.7409
2023-10-13 2023-09-30 13F Bristol-MyersSquibbCo COM 110122108 126,407 278 0.22 7 -12.50 0.9142
2023-07-11 2023-06-30 13F Bristol-Myers Squibb COM 110122108 126,129 555 0.44 8 0.00 0.9590
2023-04-17 2023-03-31 13F Bristol-Myers Squibb COM 110122108 125,574 2,641 2.15 9 0.00 1.0745
2023-01-13 2022-12-31 13F Bristol-Myers Squibb COM 110122108 122,933 -875 -0.71 9 -99.91 1.1512
2022-10-11 2022-09-30 13F Bristol-Myers Squibb COM 110122108 123,808 -384 -0.31 8,801 -7.96 1.2652
2022-07-19 2022-06-30 13F Bristol-Myers Squibb COM 110122108 124,192 -11,167 -8.25 9,562 -3.27 1.2805
2022-04-14 2022-03-31 13F Bristol-Myers Squibb COM 110122108 135,359 -762 -0.56 9,885 16.47 1.0945
2022-01-21 2021-12-31 13F Bristol-Myers Squibb COM 110122108 136,121 12,301 9.93 8,487 15.85 0.8800
2021-10-13 2021-09-30 13F Bristol-Myers Squibb COM 110122108 123,820 11,935 10.67 7,326 -2.01 0.8426
2021-07-15 2021-06-30 13F Bristol-Myers Squibb COM 110122108 111,885 44 0.04 7,476 5.89 0.8635
2021-04-05 2021-03-31 13F Bristol-Myers Squibb COM 110122108 111,841 3,271 3.01 7,060 4.84 0.8628
2021-01-12 2020-12-31 13F Bristol-Myers Squibb COM 110122108 108,570 5,005 4.83 6,734 7.86 0.8747
2020-12-03 2020-09-30 13F Bristol Myers Squibb COM 110122108 103,565 9,139 9.68 6,243 12.45 0.9058
2020-07-09 2020-06-30 13F Bristol Myers Squibb COM 110122108 94,426 7,921 9.16 5,552 15.16 0.9037
2020-04-13 2020-03-31 13F Bristol Myers Squibb COM 110122108 86,505 -7,162 -7.65 4,821 -19.81 0.9305
2020-01-29 2019-12-31 13F Bristol Myers Squibb COM 110122108 93,667 25,637 37.68 6,012 74.31 0.9133
2019-11-04 2019-09-30 13F Bristol Myers Squibb COM 110122108 68,030 2,382 3.63 3,449 15.85 0.5593
2019-08-01 2019-06-30 13F Bristol Myers Squibb COM 110122108 65,648 886 1.37 2,977 -3.63 0.4805
2019-04-29 2019-03-31 13F Bristol Myers Squibb COM 110122108 64,762 1,255 1.98 3,089 -6.42 0.5261
2019-02-07 2018-12-31 13F Bristol Myers Squibb COM 110122108 63,507 -4,068 -6.02 3,301 -21.31 0.6506
2018-10-23 2018-09-30 13F Bristol Myers Squibb COM 110122108 67,575 -149 -0.22 4,195 11.96 0.7093
2018-07-19 2018-06-30 13F Bristol Myers Squibb COM 110122108 67,724 -1,393 -2.02 3,747 -14.28 0.6786
2018-04-27 2018-03-31 13F Bristol Myers Squibb COM 110122108 69,117 380 0.55 4,371 4.74 0.8073
2018-02-09 2017-12-31 13F Bristol Myers Squibb COM 110122108 68,737 961 1.42 4,173 -3.40 0.7541
2017-11-14 2017-09-30 13F Bristol Myers Squibb COM 110122108 67,776 3,676 5.73 4,320 20.97 0.8122
2017-07-13 2017-06-30 13F Bristol Myers Squibb COM 110122108 64,100 4,305 7.20 3,571 9.84 0.7031
2017-04-12 2017-03-31 13F Bristol Myers Squibb COM 110122108 59,795 5,523 10.18 3,251 2.52 0.6681
2017-01-18 2016-12-31 13F Bristol Myers Squibb COM 110122108 54,272 6,134 12.74 3,171 22.20 0.6878
2016-10-11 2016-09-30 13F Bristol Myers Squibb COM 110122108 48,138 24,754 105.86 2,595 50.96 0.5786
2016-07-08 2016-06-30 13F Bristol Myers Squibb COM 110122108 23,384 -39 -0.17 1,719 14.91 0.4038
2016-04-14 2016-03-31 13F Bristol Myers Squibb COM 110122108 23,423 845 3.74 1,496 4.47 0.3600
2016-01-14 2015-12-31 13F Bristol Myers Squibb COM 110122108 22,578 210 0.94 1,432 8.16 0.3709
2015-10-15 2015-09-30 13F Bristol Myers Squibb COM 110122108 22,368 0 0.00 1,324 -11.02 0.3516
2015-07-02 2015-06-30 13F Bristol Myers Squibb COM 110122108 22,368 -400 -1.76 1,488 1.36 0.3724
2015-04-07 2015-03-31 13F Bristol Myers Squibb COM 110122108 22,768 -200 -0.87 1,468 8.34 0.3718
2015-03-10 2014-12-31 13F Bristol Myers Squibb COM 110122108 22,968 2,360 11.45 1,355 28.44 0.3567
2014-10-07 2014-09-30 13F Bristol Myers Squibb COM 110122108 20,608 5,356 35.12 1,055 42.57 0.2984
2014-07-16 2014-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 15,252 2,430 18.95 740 11.11 0.2145
2014-07-15 2014-06-30 13F Bristol Myers Squibb COM 110122108 15,252 740
2014-04-22 2014-03-31 13F Bristol Myers Squibb COM 110122108 12,822 0 0.00 666 -2.20 0.2066
2014-01-27 2013-12-31 13F Bristol Myers Squibb COM 110122108 12,822 0 0.00 681 14.84 0.2179
2013-10-09 2013-09-30 13F Bristol Myers Squibb COM 110122108 12,822 -1,750 -12.01 593 -8.91 0.2062
2013-07-19 2013-06-30 13F Bristol Myers Squibb COM 110122108 14,572 14,572 651 0.2359
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.